Thrombolysis with alteplase 4.5-6 hours after acute ischemic stroke

European Neurology

Volumn 65, Issue 3, 2011, Pages 170-174

  Zhang, Bin ^a   Sun, Xiao Jiang ^a   Ju, Chi Heng ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Acute treatment; Alteplase; Ischemic stroke; Recombinant tissue plasminogen activator; Thrombolytic therapy

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CLINICAL EVALUATION; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVALESCENCE; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; FIBRINOLYTIC THERAPY; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; PRIORITY JOURNAL; RANKIN SCALE; SECONDARY PREVENTION; STROKE PATIENT;

AGED; BRAIN ISCHEMIA; CHI-SQUARE DISTRIBUTION; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; MIDDLE AGED; PATIENT SELECTION; STROKE; THROMBOLYTIC THERAPY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 79952102630     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000324291     Document Type: Article

References (13)

1. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group: Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333: 1581-1587.
2. Hacke W, Donnan G, Fieschi C, Kaste M, von Kummer R, Broderick JP, Brott T, Frankel M, Grotta JC, Haley EC Jr, Kwiatkowski T, Levine SR, Lewandowski C, Lu M, Lyden P, Marler JR, Patel S, Tilley BC, Albers G, Bluhmki E, Wilhelm M, Hamilton S, ATLANTIS Trials Investigators, ECASS Trials Investigators; NINDS rt-PA Study Group Investigators: Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004; 363: 768-774.
3. Rao Mingli: The Guidelines for Cerebral Vascular Disease in China. Beijing, People's Medical Publishing House, 2004, pp 67-78.
4. Zeng Hong, Wang Xuelihong, Qi Xiaokun, Wang Hongyuan: Thrombolytic therapy using Actilyse (rt-PA) in patients with acute cerebral infarction. Chin J Emerg Med 2006; 5: 457-459.
5. Agarwal P, Kumar S, Hariharan S, Eshkar N, Verro P, Cohen B, Sen S: Hyperdense middle cerebral artery sign: can it be used to select intra-arterial versus intravenous thrombolysis in acute ischemic stroke? Cerebrovasc Dis 2004; 17: 182-190. (Pubitemid 38529196)
6. Marler JR, Glodstein LB: Medicine. Stroke - tPA and the clinic. Science 2003; 301: 1677-1679.
7. Dong-cai Y: Analysis of the time delayed and reason of the treatment for stroke victims. J Emerg Med 1999; 8: 249-251.
8. Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, Boysen G, Bluhmki E, Höxter G, Mahagne MH, Hennerici M, ECASS Study Group: Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 1995; 274: 1017-1025.
9. Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, Larrue V, Bluhmki E, Davis S, Donnan G, Schneider D, Diez-Tejedor E, Trouillas P: Randomized doubleblind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Lancet 1998; 352: 1245-1251. (Pubitemid 28470336)
10. Clark WM, Wissman S, Albers GW, Jhamandas JH, Madden KP, Hamilton S: Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. JAMA 1999; 282: 2019-2026.
11. Clark WM, Albers GW, Madden KP, Hamilton S: The rtPA (alteplase) 0- to 6-hour acute stroke trial, part A (A0276g): results of a double- blind, placebo-controlled, multicenter study. Thrombolytic therapy in acute ischemic stroke study investigators. Stroke 2000; 31: 811-816.
12. Lees KR, Bluhmki E, von Kummer R, Brott TG, Toni D, Grotta JC, Albers GW, Kaste M, Marler JR, Hamilton SA, Tilley BC, Davis SM, Donnan GA, Hacke W, ECASS, ATLANTIS, NINDS and EPITHET rt-PA Study Group, Allen K, Mau J, Meier D, del Zoppo G, De Silva DA, Butcher KS, Parsons MW, Barber PA, Levi C, Bladin C, Byrnes G: Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 2010; 15; 375: 1695-1703.
13. Yamaguchi T, Mori E, Minematsu K, Nakagawara J, Hashi K, Saito I, Shinohara Y, Japan Alteplase Clinical Trial (J-ACT) Group: Alteplase at 0.6 mg/kg for acute ischemic stroke within 3 hours of onset: Japan Alteplase Clinical Trial (J-ACT). Stroke 2006; 37: 1810-1815. (Pubitemid 44297734)